BrightSpring Health Services, Inc. (BTSG) intrinsic value & 10-year financials
BrightSpring Health Services, Inc. (BTSG) has a Graham intrinsic value of $28.90 per share. At $60.87 on Oct 17, 2026, the stock trades 111% above that value. Over the last 5 fiscal years revenue grew 18.7% a year to $12.9B, with an average return on invested capital of 9.0%.
- Graham intrinsic value
- $28.90
- Share price (Oct 17, 2026)
- $60.87
- Price vs Graham value
- 111% above
- Market cap
- $13.4B
- Revenue (FY2025)
- $12.9B
- Revenue growth (5-yr CAGR)
- 18.7%
- ROIC (10-yr avg)
- 9.0%
- Free cash flow (FY2025)
- $394.7M
BTSG 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $12.9B | $190.7M | $0.87 | $394.7M | 2.3% | 5.7% |
| FY2024 | $11.3B | -$18.1M | -$0.09 | -$57.1M | 1.8% | 2.7% |
| FY2023 | $8.8B | -$154.6M | -$1.31 | $137.3M | 1.7% | 3.1% |
| FY2022 | $7.7B | -$53.9M | -$0.46 | -$74.8M | 2.4% | 24.6% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BrightSpring Health Services, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
BrightSpring Health Services, Inc. has historically struggled to out-earn its cost of capital, averaging just 3.9% ROIC.
BrightSpring Health Services, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BrightSpring Health Services, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $28.90 per share.